|
 |
sodium oxybateThis page contains recent news articles, when available, and an overview of sodium oxybate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.However, with sodium oxybate being a form of GHB (liquid ecstasy) and given its restricted supply and a high price point, Datamonitor believes it will not ... Trading Markets (press release) Jazz Pharmaceuticals Submits New Drug Application for JZP-6 (sodium oxybate ... - Dec 15, 2009 In both trials, sodium oxybate significantly decreased pain and fatigue as well as improved daily function, patient global impression of change, ... CNNMoney.com (press release) NASDAQ's Most Advanced Today (LIMS, ARRY, SGEN, JASO, JAZZ) - Dec 15, 2009 Jazz Pharmaceuticals increased 3.06% to $8.75 after it submitted a new drug application for JZP-6 (Sodium oxybate) for the treatment of Fibromyalgia. ... Benzinga Stock Watch: InvestorSoup.com Issues Market Alert for Jazz Pharmaceuticals Inc. - Dec 10, 2009 The marketed products and late-stage product candidate of the Company include Xyrem (sodium oxybate) oral solution, Luvox CR (fluvoxamine maleate) ... FOXBusiness Jazz Pharmaceuticals Announces Third Quarter 2009 Financial Results - Nov 5, 2009 XYREM® (sodium oxybate) oral solution net sales for the third quarter of 2009 were $25.0 million, compared to $14.2 million for the third quarter of 2008, ... Reuters Fatigue, Sleep Disturbance, and Patient Global Impressions of Change Improve ... - Oct 21, 2009 PHILADELPHIA -- October 21, 2009 -- Treatment with sodium oxybate in patients with fibromyalgia incurred clinically meaningful improvements ... DG News www.standoutstocks.com: Stocks That Stand Out For Nov. 9th, 2009 Are ZAGG ... - Nov 9, 2009 XYREM(R) (sodium oxybate) oral solution net sales for the third quarter of 2009 were $25.0 million, compared to $14.2 million for the third quarter of 2008, ... Trading Markets (press release) Possible Fibromyalgia Treatment Promising - Oct 20, 2009 Research Brief: Jazz Pharmaceuticals is presenting data today (Oct. 20) from its first Phase III study of JZP-6 (sodium oxybate) as a fibromyalgia treatment ... About - News & Issues (blog) Jazz Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and ... - Nov 13, 2009 The marketed products and late-stage product candidate of the Company include Xyrem (sodium oxybate) oral solution, Luvox CR (fluvoxamine maleate) ... PR-inside.com (press release) Jazz Pharmaceuticals Inc. Reports Operating Results (10-Q) - Nov 6, 2009 During the nine months ended September 30, 2009, upon the completion of the last patient in our second Phase III pivotal clinical trial of sodium oxybate ... GuruFocus.com Stakeholder Opinions - Narcolepsy - Entry-point to a lucrative fatigue ... - Oct 23, 2009 Despite Xyrem´s (sodium oxybate) proven efficacy and its broader narcolepsy coverage than Provigil, Xyrem´s sales continue to be limited because of its ... PR-Inside.com (Pressemitteilung) Forecast Insight Fibromyalgia Regulatory caution threatens EU market expansion ... - Oct 31, 2009 Datamonitor has marginally downgraded its sales forecast for Xyrem (sodium oxybate, Jazz Pharma and UCB). This stems from a newly-highlighted concern over ... PRMinds (press release) Cell therapeutics, Inc. (CTIC), JAZZ Pharmaceuticals (JAZZ), Human Genome ... - Oct 19, 2009 ...completed phase 2b trial results, Jazz Pharmaceuticals will be presenting data from its first phase 3 trial of sodium oxybate for treating fibromyalgia. ... EON: Enhanced Online News (press release) Stocks That Stand Out For Nov. 9th, 2009 Are NUBL, HRRN, ERHE, NYMH, JAZZ - Nov 10, 2009 XYREM(R) (sodium oxybate) oral solution net sales for the third quarter of 2009 were $25.0 million, compared to $14.2 million for the third quarter of 2008, ... TMC Net Jazz Pharma 第三å£äº?æ?Ÿï¼Œè‚¡ä»·ä¸‹æŒ«7.6% - Nov 6, 2009 ...(sodium oxybate)å?£æœ?è?¯å‰‚净销售é¢?为2500万美元，2008年第三å£ä¸º1420万美元。 å…?è´£å£°æ˜Žï¼šæœ¬æ–‡ä»…ä»£è¡¨ä½œè€…ä¸ªäººè§‚ç‚¹ï¼Œä¸Žå‡¤å‡°ç½‘æ— å…³ã€‚å…¶åŽŸåˆ›æ€§ä»¥å?Šæ–‡ä¸é™ˆè¿°æ–‡å—和内容未ç»? ... 凤凰网 … and UCB Announce Positive Phase III Results for Sodium Oxybate in ... - Nov 20, 2008 Of those patients receiving sodium oxybate treatment, 46.2 percent of patients ... Sodium oxybate was generally well tolerated, with the majority of adverse ... marketwire.com Sodium Oxybate (Systemic).(Drug overview) - May 1, 2006 Sodium Oxybate(SOE-dee-um OX-ee-bait) is used to reduce the number of cataplexy (weak or paralyzed muscles) attacks in people with narcolepsy. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Sodium Oxybate (Systemic). - Oct 27, 2005 Sodium Oxybate(SOE-dee-um OX-ee-bait) is used to reduce the number of cataplexy (weak or paralyzed muscles) attacks in people with narcolepsy. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Jazz Pharmaceuticals falls in IPO debut - Jun 1, 2007 Side effects of the Jazz drug, known by its chemical name sodium oxybate, have included seizures and death. The company's Web site says that circumstances ... Reuters Xyrem(R) (Sodium Oxybate) Receives FDA Approval for the Treatment of ... - Nov 22, 2005 PALO ALTO, Calif., Nov. 22 /PRNewswire/ -- Jazz Pharmaceuticals announced today that Xyrem(R) (sodium oxybate) oral solution has been approved for marketing ... Free with registration - PR Newswire - AccessMyLibrary.com Learn about Sodium Oxybate from Consumer Reports Health. - Jan 8, 2007 Sodium oxybate is another name for GHB, a substance that is often illegally sold and abused, ... Full Alert. Sodium oxybate is used to prevent attacks of ... consumerreports.org Jazz says final patient completes late-stage pain study - Sep 11, 2008 The first study for JZP-6, also called sodium oxybate, enrolled 550 fibromyalgia ... Sodium oxybate is also the active ingredient in Jazz's drug Xyrem, ... Reuters Xyrem(R) (Sodium Oxybate) Now Available For The Treatment Of … - Mar 7, 2006 Jazz Pharmaceuticals announced today that Xyrem(R) (sodium oxybate) oral solution is now available for patients with narcolepsy who suffer from excessive ... Medical News Today - Medical News Today (press release) Sodium Oxybate Side Effects from Consumer Reports Health. - Jan 8, 2007 Sodium oxybate is another name for GHB, a substance that is often illegally sold and abused, ... Full Alert. Sodium oxybate is another name for GHB, ... consumerreports.org Sodium Oxybate Shows Promise for Treatment of Fibromyalgia - Dec 1, 2008 Since the FDA approval of Lyrica and Cymbalta for the treatment of fibromyalgia, a number of additional medications are also being tested as potential FM ... HealthCentral.com Data back broader narcolepsy indication for sodium oxybate.(Psychiatry... - Dec 15, 2005 Patients on sodium oxybate experience a deep sleep and increased arousal threshold. ... The sodium oxybate dose was 6 g/ night for the first 4 weeks and 9 g ... Free with registration - Internal Medicine News - AccessMyLibrary.com Study Finds That Xyrem(R) (Sodium Oxybate) Relieves Pain in Patients ... - Feb 23, 2006 SAN DIEGO, Feb. 23 /PRNewswire/ -- Patients with fibromyalgia syndrome taking Xyrem(R) (sodium oxybate) in a Phase II clinical trial experienced significant ... RedOrbit … narcolepsy indication for sodium oxybate.(Psychiatry) - Internal... - Dec 15, 2005 Data back broader narcolepsy indication for sodium oxybate. ... DENVER -- Sodium oxybate (Xyrem) is effective not only for cataplexy--its only approved ... Pay-Per-View - Internal Medicine News - HighBeam Research How to take Sodium Oxybate from Consumer Reports Health. - Jan 8, 2007 Sodium oxybate is another name for GHB, a substance that is often illegally sold and abused, ... Full Alert. tell your doctor and pharmacist if you are ... consumerreports.org Sodium Oxybate May Reduce Fibromyalgia Pain: Presented at AAPM - Feb 24, 2006 By Crystal Phend. SAN DIEGO, CA -- February 24, 2006 -- The sleep aid sodium oxybate (Xyrem) may also help reduce pain, tenderness, and chronic fatigue from ... DG News Article: Data back broader indication for sodium oxybate: trial... - Oct 1, 2005 Data back broader indication for sodium oxybate: trial results lead Xyrem maker to seek approval of drug for narcolepsy symptoms beyond cataplexy. Pay-Per-View - Clinical Psychiatry News - HighBeam Research Sodium oxybate may improve sleep in fibromyalgia patients.( … - Aug 1, 2008 Sodium oxybate may improve sleep in fibromyalgia patients.(Psychosomatic Medicine)(Clinical report) ... find Clinical Psychiatry News articles. Pay-Per-View - Clinical Psychiatry News - HighBeam Research New European Approval For Xyrem® Provides Significant Advance In … - Mar 12, 2007 The European Commission has approved Xyrem® (sodium oxybate) for the treatment of ... Sodium oxybate is the sodium salt of gamma hydroxybutyrate (GHB), ... Medical News Today - Medical News Today (press release) Sodium oxybate reduces daytime sleepiness in medicated narcoleptics.(... - Apr 1, 2006 MIAMI BEACH -- Sodium oxybate significantly lessened daytime sleepiness and decreased frequency of sleep attacks in people with narcolepsy concurrently ... Free with registration - Clinical Psychiatry News - AccessMyLibrary.com Press Release: Xyrem(R) (Sodium Oxybate) Receives FDA Approval for … - Nov 22, 2005 Xyrem(R) (Sodium Oxybate) Receives FDA Approval for the Treatment of Excessive Daytime Sleepiness in Patients With Narcolepsy. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Sodium oxybate reduces daytime sleepiness in medicated narcoleptics.(... - Apr 1, 2006 Sodium oxybate reduces daytime sleepiness in medicated narcoleptics.(medication usage) ... find Clinical Psychiatry News articles. Pay-Per-View - Clinical Psychiatry News - HighBeam Research Narcolepsy - Overview - NY Times Health - Feb 15, 2008 Q: The use of sodium oxybate, sold as Xyrem, to treat cataplexy has been ... What is very good about sodium oxybate is that it makes people sleep at night, ... New York Times sodium oxybate Orphan Medical completes fibromyalgia trial enrollment.... - Jan 10, 2005 Orphan Medical announced on 16 December 2004 that it has completed enrollment of over 150 patients at 20 centers in the USA in a trial of sodium oxybate ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones When the Borders Between Sleep and Wakefulness Blur - Feb 19, 2008 Q. The use of sodium oxybate, sold as Xyrem, to treat cataplexy has been ... What is very good about sodium oxybate is that it makes people sleep at night, ... New York Times Georgia Rules and Regulations - 480-34-.03 Sodium Oxybate. - Aug 10, 2005 480-34-.03 Sodium Oxybate. This Chapter was adopted to protect the health, safety, and welfare of the public. This Chapter places Sodium Oxybate (known as ... Pay-Per-View - Georgia Rules and Regulations - Loislaw … UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6)... - Nov 20, 2008 Of those patients receiving sodium oxybate treatment, 46.2 percent of patients on 4.5 ... Application for sodium oxybate to the U ... development of Jazz ... Pay-Per-View - PR Newswire - HighBeam Research … Release: Study Finds That Xyrem(R) (Sodium Oxybate) Relieves Pain... - Feb 23, 2006 Study Finds That Xyrem(R) (Sodium Oxybate) Relieves Pain in Patients With Fibromyalgia. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research European Medicines Agency Adopts Positive Opinion Recommending … - Jan 25, 2007 Sodium oxybate, the active ingredient in Xyrem(R), is a sodium salt of gamma- ... Sodium oxybate is contraindicated in patients with succinic semialdehyde ... Genetic Engineering News - Genetic Engineering News (press release) FDA Approvals: Effexor XR, Xyrem, Antara - Nov 28, 2005 18, the FDA approved a new indication for sodium oxybate (Xyrem oral solution ... Results from the first study (n = 228) showed that sodium oxybate at doses ... Medscape Press Release: Xyrem(R) (Sodium Oxybate) Now Available for the … - Mar 6, 2006 Xyrem(R) (Sodium Oxybate) Now Available for the Treatment of Excessive Daytime Sleepiness (EDS) in Patients With Narcolepsy. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research International Approvals: Femara, Xyrem, Duodopa - Dec 12, 2005 The European Commission approved in November sodium oxybate (Xyrem oral solution, ... Results showed that sodium oxybate remained effective after an average ... Medscape "Narcolepsy Drug Relieves Pain and Improves Sleep" - Nov 17, 2005 In this study, sodium oxybate was shown to be well tolerated, ... One group took 4.5 grams of sodium oxybate per day, while a second group took 6 grams per ... National Fibromyalgia Association Article: Sodium, potassium ratio affects cardiac risk.(Across... - Jun 1, 2008 Article: Data back broader indication for sodium oxybate: trial . ... But prescriptions for sodium oxybate (Xyrem) will be restricted by ... throughout the ... Pay-Per-View - Clinical Psychiatry News - HighBeam Research … : Study Finds That Xyrem(R) (Sodium Oxybate) Relieves Pain and … - Nov 17, 2005 Study Finds That Xyrem(R) (Sodium Oxybate) Relieves Pain and Improves Functioning in Patients Suffering From Fibromyalgia. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Special to CNN.com - May 16, 2006 Sodium oxybate (Xyrem). This medication controls cataplexy, ... Sodium oxybate helps to improve nighttime sleep, which is often poor in narcolepsy. ... cnn.com International Approvals: Symbicort SMART, Alimta, Xyrem - Mar 19, 2007 The European Commission has approved a new indication for sodium oxybate oral ... Sodium oxybate should not be used in patients with succinic semialdehyde ... Medscape The Risk of Motor Vehicle Accidents Involving Drivers With Prescriptio... - Nov 24, 2008 These "exclusion drugs" included all other opioids, benzodiazepines, and other hypnotics registered in Norway, as well as carisoprodol and sodium oxybate. ... Nature.com The mother who faints if she says: I love you - Jan 8, 2007 Mrs Richmond is fighting to be prescribed sodium oxybate, or Xyrem, ... "There is no cure but judging by the results so far sodium oxybate could certainly ... Daily Mail Narcolepsy Therapy; Sodium oxybate for treatment of narcolepsy … - Apr 26, 2005 2005 APR 26 - (NewsRx.com) -- A scientist reviews sodium oxybate for the treatment of narcolepsy in a recent issue of Expert Opinion on Pharmacotherapy. ... Pay-Per-View - Science Letter - Factiva, from Dow Jones Sodium oxybate Orphan Medical milestone payment UCB milestone … - Apr 4, 2005 Orphan Medical announced on 21 March 2005 that the US FDA has accepted for filing a supplemental NDA for approval of sodium oxybate (XYREM) oral solution in ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones New Study In Journal SLEEP Finds Effective Treatment For Narcoleptics - Sep 6, 2006 Taking sodium oxybate at night can significantly improve narcoleptics' quality of life ... The nightly administration of sodium oxybate produced significant ... Medical News Today - Medical News Today (press release) Jazz Pharmaceuticals Cancels Presentation Planned for November - Nov 19, 2008 Top-line Data from the First Phase III Clinical Trial of JZP-6 (sodium oxybate) for the Treatment of Fibromyalgia PR Newswire PALO ALTO, Calif., Nov. ... Bloomberg Volunteers Needed for Stanford Study of Potential Alternative to... - Oct 17, 2006 The drug, sodium oxybate, is used to treat some symptoms of narcolepsy, ... Black and his colleagues are interested in sodium oxybate because it works ... $4.95 - Business Wire - ECNext Narcolepsy Drug Gets Approval Recommendation - Jan 30, 2007 Sodium oxybate, the active ingredient in Xyrem, is a sodium salt of gamma- ... Sodium oxybate is contraindicated in patients with succinic semialdehyde ... Sleep Review Press Release: Jazz Pharmaceuticals, Inc. Completes Enrollment in... - Jun 2, 2008 Sodium oxybate is approved by the FDA for the treatment of excessive daytime ... Sodium oxybate has not been approved for the treatment of fibromyalgia. ... Pay-Per-View - PR Newswire - HighBeam Research Xyrem is Launched in Germany for the Treatment of Cataplexy in Adults... - Dec 8, 2005 Brussels, Belgium - December 8, 2005: UCB announced today that Xyrem (sodium oxybate) oral solution is now available in Germany for the treatment of ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com UCB and Jazz Pharmaceuticals announce expansion of Xyrem license … - Oct 3, 2006 Sodium oxybate is contraindicated in patients with succinic semialdehyde ... Sodium oxybate, the active ingredient in Xyrem, is a sodium salt of ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com … Final Patient Has Completed Phase III Clinical Trial Of Sodium... - Sep 12, 2008 Sodium oxybate is the active ingredient in Xyrem(R), a Jazz Pharmaceuticals ... Sodium oxybate has not been approved for the treatment of fibromyalgia. ... Medical News Today - Medical News Today (press release) => HUGIN NEWS/UCB and Jazz Pharmaceuticals announce expansion … - Mar 10, 2006 Sodium oxybate is contraindicated in patients with succinic semialdehyde ... Sodium oxybate, the active ingredient in Xyrem®, is a sodium salt of ... FinanzNachrichten.de Press Release: Jazz Pharmaceuticals Announces European Commission … - Dec 8, 2005 Sodium oxybate, the active ingredient in Xyrem, is a sodium salt of ... 552 prescriptions have been written for Xyrem(R) (sodium oxybate) oral solution ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Jazz Pharmaceuticals Announces Reduction in Force to … - Dec 16, 2008 The company will continue development of JZP-6 (sodium oxybate) for the treatment of fibromyalgia syndrome. In a recent press release, the company announced ... Pay-Per-View - PR Newswire - HighBeam Research Practice parameters discuss treatment for narcolepsy, other … - Dec 1, 2007 Sodium oxybate is effective for treatment of cataplexy, ... Sodium oxybate, tricyclic antidepressants, selective serotonin reuptake inhibitors and ... eurekalert.org Press Release: Jazz Pharmaceuticals, Inc. Announces Final Patient Has... - Sep 11, 2008 Sodium oxybate is the active ingredient in Xyrem(R), a Jazz Pharmaceuticals ... Sodium oxybate has not been approved for the treatment of fibromyalgia. ... Pay-Per-View - PR Newswire - HighBeam Research Existing Drugs Being Examined as Fibromyalgia Treatment: PAINWeek - Sep 11, 2007 Sodium oxybate (Xyrem®), also known as gamma hydroxybutyrate, ... Designs for phase 3 trials for sodium oxybate are now underway, he said. ... DG News Jazz Pharmaceuticals Announces Phase III Clinical Trial to Study the ... - Sep 7, 2006 Sodium oxybate, the active ingredient in Xyrem, is a sodium salt of gamma- hydroxybutyrate, a substance with a history of abuse when acquired illicitly and ... Free with registration - PR Newswire - AccessMyLibrary.com Sleep: A Comprehensive Handbook - Apr 18, 2007 Chapter 26, discussing specific pharmacological treatments of sleepiness, such as modafinil, methylphenidate, and sodium oxybate, could have included ... Journal of American Medical Association - Journal of American Medical Association... Xyrem® Trial Currently Recruiting FM Patients in Many States - Oct 6, 2006 Should the pharmaceutical drug Xyrem® (sodium oxybate) become the first ... A previous US-based trial of sodium oxybate, a “central nervous system ... ProHealth Article: Cypress stock drops following inconclusive test results.(Cypr... - Oct 10, 2005 ...the final patient has completed participation in the first Phase III pivotal clinical trial of JZP-6 (sodium oxybate) for the treatment of fibromyalgia. ... Pay-Per-View - San Diego Business Journal - HighBeam Research Jazz Pharmaceuticals, Inc. Cuts 67 Jobs, Q3 Loss Grows to $28.8M - Nov 13, 2008 XYREM(R) (sodium oxybate oral solution) net sales for the third quarter of 2008 increased 48 percent to $14.2 million, compared with $9.6 million for the ... FierceBiotech Press Release: Jazz Pharmaceuticals Signs Licensing Agreement With … - Jan 12, 2007 Jazz Pharmaceuticals has signed an agreement licensing the Canadian marketing rights ... its oral drug Xyrem (sodium oxybate) to fellow USA-based Valeant ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Jazz Pharmaceuticals Announces Phase III Clinical... - Sep 7, 2006 Jazz Pharmaceuticals Announces Phase III Clinical Trial to Study the Safety and Efficacy of Xyrem(R) (Sodium Oxybate) in Patients With Fibromyalgia ... Pay-Per-View - PR Newswire - HighBeam Research Washington Administrative Code - WAC 246-887-165 The Washington … - Mar 17, 2006 The Washington state board of pharmacy finds that Xyrem, sodium oxybate, Gamma-hydroxybutyric (GHB), is approved for medical use by the Food and Drug ... Pay-Per-View - Washington Administrative Code - Loislaw Mayo Clinic expertise - May 16, 2008 Sodium oxybate (Xyrem). This medication controls cataplexy in people ... Sodium oxybate helps to improve nighttime sleep, which is often poor in narcolepsy. ... MayoClinic.com Jazz Pharmaceuticals Announces European Commission Marketing … - Dec 9, 2005 Sodium oxybate, the active ingredient in Xyrem, is a sodium salt of gamma-hydroxybutyrate, a substance with a history of abuse when acquired illicitly and ... biotech-intelligence.com Tennessee Acts - CHAPTER NO. 298 OF THE PUBLIC ACTS OF 2007 - May 30, 2007 ...alphabetizing and renumbering the existing subdivisions: (2) Gamma hydroxybutyric acid (3) Sodium oxybate (4) Gamma hydroxybutyrate sodium SECTION 14. ... Pay-Per-View - Tennessee Acts - Loislaw Press Release: Jazz Pharmaceuticals Announces Settlement of … - Jul 13, 2007 Commenting on the ... marketing in the United States for the treatment ... is marketed in the United States by Jazz Pharmaceuticals. Sodium oxybate ... ... Pay-Per-View - PR Newswire - HighBeam Research Jazz Pharmaceuticals announces Q2 2008 financial results. - Aug 8, 2008 Net sales of prescription drug XYREM (sodium oxybate oral solution), used for the treatment of narcolepsy, for the second quarter of 2008 increased 29% to ... $9.94 - M2 Europharma - Alacra Store Factiva Search - Apr 29, 2005 Narcolepsy Therapy; Sodium oxybate for treatment of narcolepsy reviewed ... 2005 APR 29 - (NewsRx.com) -- A scientist reviews sodium oxybate for the ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Factiva Search - Apr 27, 2005 Albert Einstein College of Medicine; Sodium oxybate for treatment of narcolepsy ... 2005 APR 27 - (NewsRx.com) -- A scientist reviews sodium oxybate for the ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones Article: Armodafinil improves daytime wakefulness in CPAP users.( … - Feb 1, 2006 Article: Sodium oxybate reduces daytime sleepiness in medicated ... ... Article: Data back broader indication for sodium oxybate: trial results ... ... Pay-Per-View - Clinical Psychiatry News - HighBeam Research Press Release: Narcolepsy Drug Relieves Pain and Improves Sleep in … - Nov 17, 2005 Data on Xyrem(R) (sodium oxybate) presented today at the American College of Rheumatology annual meeting. ORANGE, Calif., Nov. ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Jazz Pharmaceuticals Cancels Presentation Planned for ... - Nov 19, 2008 Company Expects Release of Preliminary Top-line Data from the First Phase III Clinical Trial of JZP-6 (sodium oxybate) for the Treatment of Fibromyalgia ... Pay-Per-View - PR Newswire - HighBeam Research Excessive daytime sleepiness may signal elevated stroke risk.(Across ... - May 1, 2008 Article: Sodium oxybate reduces daytime sleepiness in ... ... Sodium oxybate significantly lessened daytime sleepiness and decreased frequency of sleep ... Pay-Per-View - Clinical Psychiatry News - HighBeam Research Jazz Pharmaceuticals Reports RIF | Article from Wireless News | … - Dec 22, 2008 Jazz Pharmaceuticals currently markets and sells Xyrem (sodium oxybate) and ... The company will continue development of JZP-6 (sodium oxybate) for the ... Pay-Per-View - Wireless News - HighBeam Research Mobility limitations in diabetes.(CLINICAL CAPSULES) | Article from … - Mar 1, 2006 Article: Sodium Oxybate Works for Cataplexy, but Has Abuse Potential. ... The two-sided nature of sodium oxybate led to a decidedly schizophrenic ... Pay-Per-View - Internal Medicine News - HighBeam Research Use multidisciplinary approach in fibromyalgia.(Psychosomatic... - May 1, 2007 Article: Sodium oxybate may improve sleep in fibromyalgia ... ... PHOENIX--Preliminary data on the off-label use of sodium oxybate suggest that it improved ... Pay-Per-View - Clinical Psychiatry News - HighBeam Research Access to HPV vaccine may hit funding barriers.(Practice Trends) |... - Dec 1, 2006 Article: Sodium Oxybate Works for Cataplexy, but Has Abuse Potential. ... But prescriptions for sodium oxybate ... patients in the United States. ... Pay-Per-View - Internal Medicine News - HighBeam Research From Faithful Dogs and Difficult Fish, Insight Into Narcolepsy - Oct 23, 2007 To suppress paralysis, patients take antidepressants or sodium oxybate, found in the date-rape drug. None of the medicines influence the hypocretin system. ... New York Times Insomnia: dying for a good night's sleep - Apr 14, 2008 But again new drugs such as sodium oxybate, are proving very effective. Then there are conditions linked under the "parasomnia" umbrella, ... Telegraph.co.uk Narcolepsy - Overview - NY Times Health - Feb 15, 2008 The arrival in 1999 of the wakefulness-promoting drug modafinil, followed in 2002 by the sedative sodium oxybate, has also made a big difference for many. ... New York Times Word of the Day - Nov 5, 2007 To suppress paralysis, patients take antidepressants or sodium oxybate, found in the date-rape drug. None of the medicines influence the hypocretin system. New York Times Article: Nancy C. Phelps* Age: 58 Res ... - The Washington Post | … - Aug 31, 2006 ...has recommended Orphan Designation in Europe for Xyrem(R) (sodium oxybate) oral solution for the treatment of narcolepsy. The positive recommendation . ... Pay-Per-View - Washington Post - HighBeam Research Efforts intensify to treat pain disorder ; Advances show promise for ... - Mar 16, 2005 Another type of drug that may help reduce fibromyalgia symptoms is a new sleep-inducing drug, sodium oxybate. Used in patients with the sleep disorder ... Pay-Per-View - Chicago Tribune - ProQuest Archiver Article: Dalton Wood Jr.* Age: ... - The Washington Post | HighBeam … - Aug 31, 2006 ...has recommended Orphan Designation in Europe for Xyrem(R) (sodium oxybate) oral solution for the treatment of narcolepsy. The positive recommendation . ... Pay-Per-View - Washington Post - HighBeam Research Paralysed by saying I love you - Jan 4, 2007 She is trying to secure NHS funding for a new drug, sodium oxybate, which doctors believe could help her. The drug, marketed as Xyrem, has just been ... Metro Jazz' cataplexy drug gains EU approval. - Dec 19, 2005 California, USA-based drugmaker Jazz Pharmaceuticals says that the European Commission has granted marketing approval for Xyrem (sodium oxybate) oral ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Bloomberg Printer-Friendly Page - Jul 16, 2008 ...to complete the Phase III clinical studies of JZP-6 (sodium oxybate) for the treatment of fibromyalgia, and for general corporate purposes. ... Bloomberg Time at last to let narcoleptic dogs lie - Dec 6, 2007 To suppress paralysis, patients take antidepressants or sodium oxybate. Mignot is now asking why hypocretin neurons die in narcoleptic people. ... Sydney Morning Herald Utility of cognitive behavioral therapy as a treatment for insomnia... - Feb 14, 2006 Several antidepressants, including zolpidem tartrate and sodium oxybate have been shown to have short-term effects on insomnia related to fibromyalgia, ... Nature.com Article: Buyout offer for Orphan Medical; The deal for the Minnetonka... - Apr 20, 2005 Pharma Marketletter; November 28, 2005 ; 554 words ... ... results from a recent study of the narcolepsy drug Xyrem (sodium oxybate), which is marketed by ... Pay-Per-View - Star Tribune - HighBeam Research Sleeping makes me a monster - Feb 20, 2007 There is the possibility I could try sodium oxybate, a different form of drug that can help, but that hasn't yet been confirmed. ... Daily Mail WHEN DRUGS EXPIRE, DON'T TAKE THEM, BUT DON'T JUST TOSS … - Sep 3, 2008 ...meperidine HCl tablets, Percocet tablets and capsules (oxycodone/acetaminophen), Xyrem (sodium oxybate) and Fentora (fentanyl buccal tablets). ... $2.95 - St. Paul Pioneer Press - NewsBank Article: FORMULA WOULD TREAT RAYNAUD'S DISEASE MEDIQUEST … - Apr 30, 2008 Newswire/ -- The Food and Drug Administration's (FDA) approval today of the new drug Xyrem(r) (sodium oxybate) for treating the ... dreams. ... Pay-Per-View - Seattle Post-Intelligencer - HighBeam Research DRUG CAPSULE WHAT YOU SHOULD KNOW | Article from The … - Oct 9, 2006 Interactions: Do not take this drug in combination with sodium oxybate or MAO inhibitors. More info: www.webmd.com; www.medicinenet.com/migraine_headache/ ... Pay-Per-View - Milwaukee Journal Sentinel - HighBeam Research DRUG CAPSULE WHAT YOU SHOULD KNOW - Oct 9, 2006 Dichloralphenazone helps relax the body. Interactions: Do not take this drug in combination with sodium oxybate or MAO inhibitors. More info: www.webmd.com; ... $2.95 - Milwaukee Journal Sentinel - NewsBank Product news from the 03/17/06 News Brief - Mar 17, 2006 Jazz Pharmaceuticals announced that Xyrem (sodium oxybate) oral solution is now available for patients with narcolepsy who suffer from excessive daytime ... Medical Marketing & Media - Medical Marketing and Media Deals: No IPO for Organon - Apr 1, 2007 Xyrem (sodium oxybate) for excessive daytime sleepiness and cataplexia in patients with narcolepsy (2006 sales, $29 million.) ... PharmExec.com ORPHAN MEDICAL SUBMITS XYREM SNDA TO FDA. - Mar 1, 2005 Orphan Medical, Inc. (Nasdaq:ORPH), Minneapolis, has submitted a Supplemental New Drug Application (sNDA) for Xyrem(R) (sodium oxybate) oral solution to the ... Entrepreneur Drugs In Our Drinking Water? How To Dispose Of Your Medications … - Mar 13, 2008 Duragesic Transdermal System, Fentora), oxycodone (Oxycontin, Percocet), meperidine, and morphine (Avinza); the narcolepsy drug sodium oxybate (Xyrem); ... Medical News Today - Medical News Today (press release) Orphan Medical Issues 2005 Xyrem Prescriptions Update - May 23, 2005 ...(Nasdaq:ORPH) announced that the total number of Xyrem(R) (sodium oxybate) oral solution prescriptions filled in the six-week period ended May 15, 2005, ... RedOrbit |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |